Monitoring of Biopsy-Proven Interstitial Polyomavirus Nephritis in Kidney and Kidney Pancreas Transplant Recipients
Information source: University of Cincinnati
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Polyomavirus
Phase: N/A
Status: Completed
Sponsored by: University of Cincinnati Official(s) and/or principal investigator(s):
Prabir Roy-Chaudhury, MD, PhD, Principal Investigator, Affiliation: University of Cincinnati
Summary
Evaluate techniques for monitoring the course of interstitial therapy for polyomavirus
nephritis in kidney and kidney pancreas transplant recipients by monitoring blood, urine, and
renal transplant biopsies of patients affected by polyomavirus.
Clinical Details
Official title: Monitoring of Biopsy-Proven Interstitial Polyomavirus Nephritis in Kidney and Kidney Pancreas Transplant Recipients
Study design: Prospective
Detailed description:
Evaluate techniques for monitoring the course of interstitial therapy for polyomavirus
nephritis in kidney and kidney pancreas transplant recipients by monitoring blood, urine, and
renal transplant biopsies of patients affected by polyomavirus.
Eligibility
Minimum age: 18 Years.
Maximum age: 70 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Recipients of a kidney or kidney pancreas transplant diagnosed with biopsy proven
interstitial nephritis due to polyomavirus.
- Age 18 to 70 years.
- Capable of providing written informed consent.
Exclusion Criteria:
- Age less than 18 years or greater than 70 years.
- Patient is on chronic warfarin or heparin therapy or has a disease that puts them at
risk of bleeding.
Locations and Contacts
University of Cincinnati, Cincinnati, Ohio 45267, United States
The Christ Hospital, Cincinnati, Ohio 45267, United States
Additional Information
Starting date: June 2001
Ending date: October 2007
Last updated: December 20, 2007
|
